Ann: Synthetic Bone Substitute Licence from Unive, page-7

Doing research on AMT. Fits my speculative criteria.

Same increase in earnings this FY would have the company in profit, and has a low P/B of under 1.

Liquidity is a big issue though, if you put in a substancial sum, there's no gaurentee to get it back at anywhere near value.

Would like to know more from those in the know.